Risk of bleeding and hypoprothrombinaemia associated with NMTT side chain antibiotics: using cefoperazone as a test case

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Pharmacoepidemiology and Drug Safety

• Publication date

  1999-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/(SICI)1099-1557(199903/04)8:2<81::AID-PDS411>3.0.CO;2-GPMID 15073933
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tests for trend and dose response: misinterpretations and alternatives.

  1992cited by this paper
• Prospective Evaluation of Risk Factors for Antibiotic‐Associated Bleeding in Critically III Patients

  1992cited by this paper
• Prospective Surveillance of Antibiotic‐Associated Coagulopathy in 970 Patients

  1989influential reference
• Mechanism of Cephalosporin‐induced Hypoprothrombinemia: Relation to Cephalosporin Side Chain, Vitamin K Metabolism, and Vitamin K Status

  1988cited by this paper
• Determinants of Antibiotic‐associated Hypoprothrombinemia

  1987cited by this paper
• Hypoprothrombinemia Associated With Cefoperazone Therapy

  1987cited by this paper
• Cefoperazone for empiric therapy in patients with impaired renal function.

  1986cited by this paper
• Potential for bleeding with the new beta-lactam antibiotics.

  1986cited by this paper
• Enhanced bleeding with cefoxitin or moxalactam. Statistical analysis within a defined population of 1493 patients.

  1986cited by this paper
• Cephalosporin-induced hypoprothrombinemia: is the N-methylthiotetrazole side chain the culprit?

  1986cited by this paper
• A high incidence of bleeding is observed in a trial to determine whether addition of metronidazole is needed with latamoxef for prophylaxis in colorectal surgery.

  1985cited by this paper
• Clinical risk factors for prolonged PT/PTT in abdominal sepsis patients treated with moxalactam or tobramycin plus clindamycin.

  1985cited by this paper
• A high incidence of bleeding is observed in a trial to determine whether addition of metronidazole is needed with latamoxef for prophylaxis in colorectal surgery.

  1985cited by this paper
• Multicenter clinical trial of cefoperazone sodium in the United States.

  1984influential reference
• Nontropical chyluria secondary to massive mesenteric adenitis. Case report with metabolic and immunologic studies.

  1984cited by this paper
• Coagulation abnormalities induced by beta-lactam antibiotics in cancer patients.

  1983cited by this paper
• A Randomized Clinical Trial of Moxalactam Alone versus Tobramycin plus Clindamycin in Abdominal Sepsis

  1983cited by this paper
• N-methyl-thio-tetrazole inhibition of the gamma carboxylation of glutamic acid: possible mechanism for antibiotic-associated hypoprothrombinaemia.

  1983cited by this paper
• Epidemiologic Research: Principles and Quantitative Methods.

  1983cited by this paper
• Coagulation Abnormalities Induced by β-Lactam Antibiotics in Cancer Patients

  1983cited by this paper
• Odds ratio estimators when the data are sparse

  1981cited by this paper
• Use of the logistic model in retrospective studies.

  1976cited by this paper
• Confounding and effect-modification.

  1974cited by this paper
• Statistical methods for rates and proportions

  1973cited by this paper
• Estimation of the multivariate logistic risk function: a comparison of the discriminant function and maximum likelihood approaches.

  1971cited by this paper
• Chi-square tests with one degree of freedom

  1963cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper

• The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model

  2025cites this paper
• Development and internal validation of a model for predicting cefoperazone/sulbactam-associated coagulation disorders in Chinese inpatients

  2024cites this paper
• Cefoperazone-Sulbactam-Induced Coagulopathy in Critically Ill Egyptian Patients: Role of Vitamin K Prophylactic Doses

  2024cites this paper
• Serum trough concentration threshold and risk factors of cefoperazone-induced coagulopathy in critically ill patients: A retrospective case-control study

  2024influential citation
• Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies

  2023influential citation
• Risk Factors for Cefoperazone/Sulbactam-Induced Coagulation Disorder

  2023cites this paper
• Cefoperazone-induced Coagulopathy in Critically Ill Patients Admitted to Intensive Care Unit

  2023cites this paper
• A Review on Drug Induced Hematological Disorders

  2022cites this paper
• Latamoxef‐induced coagulation disorders: Incidence and risk factors

  2021cites this paper
• Vitamin B12 may inhibit RNA‐dependent‐RNA polymerase activity of nsp12 from the SARS‐CoV‐2 virus

  2020cites this paper
• Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study

  2020influential citation
• EVALUATION OF CEFOPERAZONE/SULBACTAM AND VITAMIN K USE IN PATIENTS WITH BACTERIAL INFECTIONS

  2019cites this paper
• Development and Validation of a Risk Scoring System for Cephamycin-Associated Hemorrhagic Events

  2019cites this paper
• The Association Between Cephalosporin and Hypoprothrombinemia: A Systematic Review and Meta-Analysis

  2019influential citation
• Elevated PT, APPT and PT/INR possibly associated with doxycycline and cefoperazone co‐administration: A case report

  2018cites this paper
• Chapter 2 – Pharmacologic Principles

  2018cites this paper
• Structure‐toxicity relationship of cefoperazone and its impurities to developing zebrafish by transcriptome and Raman analysis

  2017cites this paper
• Use of Hypoprothrombinemia-Inducing Cephalosporins and the Risk of Hemorrhagic Events: A Nationwide Nested Case-Control Study

  2016influential citation
• Cefoperazone/Sulbactam-Induced Abdominal Wall Hematoma and Upper Gastrointestinal Bleeding: A Case Report and Review of the Literature

  2016influential citation
• Cefoperazone Induced Gastrointestinal Bleeding.

  2016cites this paper
• Risk of bleeding and antibiotic use in patients receiving continuous phenprocoumon therapy

  2014cites this paper
• Effect of Withania somnifera Extracts on Some Selective Biochemical, Hematological, and Immunological Parameters in Guinea Pigs Experimental Infected with E. coli

  2013cites this paper
• Hemarthrosis in a Patient on Warfarin Receiving Ceftaroline: A Case Report and Brief Review of Cephalosporin Interactions with Warfarin

  2012cites this paper
• Effect of Fasting on Coagulation Factors in Patients who Undergo Major Abdominal Surgery

  2010cites this paper
• Drug-Induced Hematologic Syndromes

  2009cites this paper
• Severe INR Elevation in a Patient with Choledocholithiasis Receiving Cefoperazone

  2006cites this paper